(19)
(11) EP 2 811 939 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
15.11.2017 Bulletin 2017/46

(45) Mention of the grant of the patent:
20.09.2017 Bulletin 2017/38

(21) Application number: 13746917.7

(22) Date of filing: 11.02.2013
(51) International Patent Classification (IPC): 
A61F 2/24(2006.01)
(86) International application number:
PCT/US2013/025591
(87) International publication number:
WO 2013/120082 (15.08.2013 Gazette 2013/33)

(54)

PRODUCTS MADE OF BIOLOGICAL TISSUES FOR STENTS AND METHODS OF MANUFACTURING

PRODUKT AUS BIOLOGISCHEM GEWEBE FÜR STENTS UND HERSTELLUNGSVERFAHREN

PRODUITS DE TISSUS BIOLOGIQUES POUR ENDOPROTHÈSES VASCULAIRES ET PROCÉDÉS DE FABRICATION


(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 10.02.2012 US 201261597406 P
30.04.2012 US 201261640381 P

(43) Date of publication of application:
17.12.2014 Bulletin 2014/51

(60) Divisional application:
17191957.4

(73) Proprietor: CVDevices, LLC
San Diego CA 92121 (US)

(72) Inventors:
  • KASSAB, Ghassan S.
    Zionsville, IN 46077 (US)
  • NAVIA, Jose A.
    Buenos Aries 1011 (AR)
  • JORDANA, Jorge
    Buenos Aires C1426 BWX (AR)
  • BERWICK, Zachary C.
    Indianapolis, IN 46217 (US)

(74) Representative: Garratt, Peter Douglas et al
Mathys & Squire LLP
The Shard 32 London Bridge Street London SE1 9SG
The Shard 32 London Bridge Street London SE1 9SG (GB)


(56) References cited: : 
EP-A1- 1 452 153
WO-A1-98/46165
WO-A1-2005/003285
WO-A1-2010/091188
WO-A1-2011/056234
WO-A2-2006/026325
WO-A2-2006/060546
WO-A2-2010/065843
WO-A2-2011/109450
US-A- 5 571 174
US-A1- 2005 130 928
US-A1- 2007 172 447
US-A1- 2008 275 550
US-A1- 2010 093 023
US-A1- 2012 004 677
WO-A1-97/12565
WO-A1-03/092554
WO-A1-2006/124021
WO-A1-2010/091188
WO-A2-03/057844
WO-A2-2006/026325
WO-A2-2008/073582
WO-A2-2011/109450
US-A- 4 218 782
US-A- 6 003 517
US-A1- 2005 273 160
US-A1- 2008 097 496
US-A1- 2008 287 878
US-A1- 2011 300 131
   
  • GULBINS, H ET AL.: 'Preseeding with autologous fibroblasts improves endothelialization of glutaraldehyde-fixed porcine aortic vlaves.' J THORAC CARDIOVASC SURG March 2003, pages 592 - 601, XP055078313
  • GRANT W. CHRISTIE ET AL: "Age-dependent changes in the radial stretch of human aortic valve leaflets determined by biaxial testing", THE ANNALS OF THORACIC SURGERY, vol. 60, 1 August 1995 (1995-08-01), pages S156-S159, XP055341609, United States ISSN: 0003-4975, DOI: 10.1016/0003-4975(95)00219-B
   
Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).